Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago [Yahoo! Finance]
CytomX Therapeutics, Inc. (CTMX)
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cytomx.com
Company Research
Source: Yahoo! Finance
Spare a thought for those who held CytomX Therapeutics, Inc. NASDAQ:CTMX ) for five whole years - as the share price tanked 83%. Unfortunately the share price momentum is still quite negative, with prices down 62% in thirty days. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson. With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies. View our latest analysis for CytomX Therapeutics There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During five years of share price growth, CytomX Therapeutics moved from a loss to profitability. Most would consider that to be a good
Show less
Read more
Impact Snapshot
Event Time:
CTMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTMX alerts
High impacting CytomX Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CTMX
News
- CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual ConferenceGlobeNewswire
- CytomX Therapeutics, Inc. (NASDAQ: CTMX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- CytomX Therapeutics Promotes Chris Ogden to Chief Financial OfficerGlobeNewswire
- CytomX Therapeutics, Inc. (NASDAQ: CTMX) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $3.50 price target on the stock, up previously from $2.25.MarketBeat
CTMX
Earnings
- 5/8/24 - Miss
CTMX
Sec Filings
- 6/17/24 - Form 8-K
- 6/14/24 - Form 4
- 5/22/24 - Form SC
- CTMX's page on the SEC website